Display options
Cite
Andresen V, Keller J, Pehl C, et al. Irritable bowel syndrome--the main recommendations. Dtsch Arztebl Int. 2011;108(44):751-60doi: 10.3238/arztebl.2011.0751.
Andresen, V., Keller, J., Pehl, C., Schemann, M., Preiss, J., & Layer, P. (2011). Irritable bowel syndrome--the main recommendations. Deutsches Arzteblatt international, 108(44), 751-60. https://doi.org/10.3238/arztebl.2011.0751
Andresen, Viola, et al. "Irritable bowel syndrome--the main recommendations." Deutsches Arzteblatt international vol. 108,44 (2011): 751-60. doi: https://doi.org/10.3238/arztebl.2011.0751
Andresen V, Keller J, Pehl C, Schemann M, Preiss J, Layer P. Irritable bowel syndrome--the main recommendations. Dtsch Arztebl Int. 2011 Nov;108(44):751-60. doi: 10.3238/arztebl.2011.0751. Epub 2011 Nov 04. PMID: 22163251; PMCID: PMC3226958.
Copy Download .nbib Format: NLM
Share it on

Dtsch Arztebl Int. 2011 Nov;108(44):751-60. doi: 10.3238/arztebl.2011.0751. Epub 2011 Nov 04.

Irritable bowel syndrome--the main recommendations.

Deutsches Arzteblatt international

Viola Andresen, Jutta Keller, Christian Pehl, Michael Schemann, Jan Preiss, Peter Layer

Affiliations

  1. Israelitisches Krankenhaus Medizinische Klinik, Hamburg, Germany. [email protected]

PMID: 22163251 PMCID: PMC3226958 DOI: 10.3238/arztebl.2011.0751

Abstract

BACKGROUND: Irritable bowel syndrome is characterized by chronic abdominal symptoms and irregular bowel movements without any cause than can be revealed by routine diagnostic assessment. In recent years, its pathophysiology has come to be much better understood, and new therapeutic approaches have been developed. These advances were taken into consideration and assessed for their relevance to clinical practice in the framework of a new interdisciplinary S3 guideline.

METHODS: A systematic search of the literature retrieved a total 5573 articles, from which 243 were selected on the basis of criteria relating to their form and content, individually assessed, and summarized in evidence tables. The recommendations formulated in this way were discussed in a Delphi procedure and a consensus conference, then accordingly modified and finalized.

RESULTS: Variable symptom constellations are caused by disturbances of gastrointestinal regulation at multiple levels. The diagnosis of irritable bowel syndrome requires both chronic bowel symptoms that interfere with everyday life and the exclusion of relevant differential diagnoses. Its treatment is based on general therapeutic principles, dietary recommendations, psychological components, and symptomatic medication. Bulking agents, laxatives, spasmolytics, loperamide, and probiotic agents are recommended (with variable recommendation strengths), as are--for selected patients--antidepressants, 5-HT4 agonists, 5-HT3 antagonists, and topical antibiotics.

CONCLUSION: The first German S3 guideline on irritable bowel syndrome translates up-to-date scientific knowledge as represented in current publications into concrete recommendations for diagnosis and treatment in clinical practice. In the future, it is likely that further causative pathophysiological mechanisms will be discovered; this should lead, in turn, to the development of new, causally directed treatments, which will supplement or replace the traditional, purely symptomatic treatments that are still in use today.

References

  1. Gynecol Oncol. 2003 Jul;90(1):75-82 - PubMed
  2. Clin Gastroenterol Hepatol. 2008 May;6(5):545-55 - PubMed
  3. N Engl J Med. 2008 May 29;358(22):2344-54 - PubMed
  4. Scand J Gastroenterol. 2000 Mar;35(3):306-11 - PubMed
  5. Am J Gastroenterol. 2007 Nov;102(11):2520-8 - PubMed
  6. Z Gastroenterol. 2011 Feb;49(2):237-93 - PubMed
  7. BMJ. 2008 Nov 13;337:a2313 - PubMed
  8. Am J Gastroenterol. 2009 Jul;104(7):1831-43; quiz 1844 - PubMed
  9. Gastroenterology. 2006 Apr;130(5):1480-91 - PubMed
  10. Scand J Gastroenterol. 1996 May;31(5):463-8 - PubMed
  11. BMC Gastroenterol. 2009 Feb 16;9:15 - PubMed
  12. Fortschr Med. 1990 Aug 30;108(25):488-92 - PubMed
  13. Gastroenterology. 2010 Dec;139(6):1877-1886.e2 - PubMed
  14. N Engl J Med. 2011 Jan 6;364(1):22-32 - PubMed
  15. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005111 - PubMed
  16. Gastroenterology. 2009 May;136(6):1979-88 - PubMed
  17. Lancet. 2001 Nov 3;358(9292):1504-8 - PubMed
  18. Am J Gastroenterol. 2002 Jun;97(6):1463-7 - PubMed
  19. Gut. 2010 Mar;59(3):325-32 - PubMed
  20. Dig Dis Sci. 2004 Mar;49(3):469-74 - PubMed
  21. Ann Intern Med. 1995 Jan 15;122(2):107-12 - PubMed
  22. JAMA. 2004 Jun 9;291(22):2705-12 - PubMed
  23. Z Gastroenterol. 2011 Mar;49(3):374-90 - PubMed
  24. Cancer. 2007 Jan 15;109(2):221-7 - PubMed
  25. Aliment Pharmacol Ther. 2006 Jan 1;23(1):191-6 - PubMed
  26. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003460 - PubMed
  27. World J Gastroenterol. 2008 May 7;14(17):2650-61 - PubMed
  28. BMJ. 2009 Aug 25;339:b2998 - PubMed
  29. Am J Gastroenterol. 2010 Apr;105(4):866-75 - PubMed
  30. Gut. 2009 Mar;58(3):367-78 - PubMed
  31. Arch Intern Med. 2009 Apr 13;169(7):651-8 - PubMed
  32. Fam Pract. 2005 Oct;22(5):548-53 - PubMed

MeSH terms

Publication Types